More Trouble Keeps Brewing at Dave & Buster’s

After Dave & Buster’s released its most recent quarterly results, the stock hit a new 52-week low.

Published April 4, 2018, 11:40am ET · 2 min read

© Thinkstock

After Dave & Buster’s Entertainment Inc. (NASDAQ: PLAY) released its most recent quarterly results late on Tuesday, the stock hit a 52-week low—a level not seen since late 2016—on Wednesday. This despite management citing that it had a record performance for the quarter. Analysts were not optimistic.

The company said that it had $0.61 in earnings per share (EPS) on $304.9 million in revenue, in line with consensus estimates of $0.61 in EPS on revenue of $305 million. In the same period of last year, the company said it had EPS of $0.63 and $270.2 million in revenue.

During the quarter, comparable store sales decreased 5.9%. Dave & Buster’s also opened five new stores in this time.

CEO Steve King commented:

2017 was another outstanding year for us as we delivered double-digit revenue, Net Income and EBITDA growth. Our primary growth vehicle and the biggest driver of value continues to be opening stores that offer excellent returns in the face of a more intense competitive environment. However, recent sales trends in our comparable stores have been disappointing and we are working diligently to re-build momentum by evolving the brand.

In terms of the analysts, Canaccord Genuity maintained a Buy rating ahead of the virtual reality launch, with a $60 price target. The firm believes that additional patience is required, but the risk/reward remains favorable.

Here’s what other analysts had to say after the report:

  • BMO has an Outperform rating and cut its price target to $49 from $60‍.
  • Jefferies has a Buy rating and cut its price target from $63 to $51.
  • Maxim cut its price target to $62 from $74‍.
  • Raymond James cut its price target from $55 to $52.50.
  • SunTrust Robinson Humphrey cut its target to $54 from $70.

Shares of Dave & Buster’s were last seen down about 3% at $39.33, with a consensus analyst price target of $62.22 and a 52-week trading range of $37.85 to $73.48.

Contact [email protected] for any questions or corrections.

Chris Lange

Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.

His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.

When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.

All articles →